NUFLAM

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

glucosamine sulfate potassium chloride, Quantity: 667 mg (Equivalent: glucosamine sulfate, Qty 500 mg; Equivalent: potassium chloride, Qty 167 mg); shark chondroitin sulfate, Quantity: 278 mg (Equivalent: chondroitin sulfate, Qty 250 mg)

Disponível em:

Zifam Pinnacle Pty Ltd

Forma farmacêutica:

Capsule, hard

Composição:

Excipient Ingredients: Gelatin; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; purified water; titanium dioxide; iron oxide yellow; quinoline yellow

Via de administração:

Oral

Indicações terapêuticas:

Maintain/support general health and wellbeing ; Decrease/reduce/relieve mild joint aches and pains ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Helps maintain/supports healthy joint cartilage growth/development/production ; Maintain/support joint health ; Maintain/support joint mobility/flexibility

Resumo do produto:

Visual Identification: ; Container Type: Multiple containers

Status de autorização:

Listed

Data de autorização:

2020-12-24